Literature DB >> 24932446

Learning about PRP using cell-based models.

Knut Beitzel1, Mary Beth McCarthy2, Ryan P Russell2, John Apostolakos2, Mark P Cote2, Augustus D Mazzocca2.   

Abstract

Studies using in vitro cell models enable evaluation of the effects of different PRP products under very controlled and standardized conditions. Therefore the results of such studies build the basis for understanding the variable results of clinical studies on the use of PRPs. The main lessons learned through the use of in vitro cell models are that many different PRP products exist and researchers have to report on component variation within each product. These different products may have distinctive effects on the various cells treated in musculoskeletal injuries; therefore, some products might be more beneficial in certain indication than others. In its utilization in cell models, PRP may generate a variety of positive effects on cell proliferation, recovery, and inflammatory response. There might also be a benefit to adding PRP to current pharmacological therapies (e.g. corticosteroids) to prevent their commonly known negative effects on e.g. tendon and cartilage tissue.

Entities:  

Keywords:  PRP; in vitro; platelet-rich plasma; tendon; tenocytes

Year:  2014        PMID: 24932446      PMCID: PMC4049649     

Source DB:  PubMed          Journal:  Muscles Ligaments Tendons J        ISSN: 2240-4554


  62 in total

1.  Platelet-rich plasma (PRP): what is PRP and what is not PRP?

Authors:  R E Marx
Journal:  Implant Dent       Date:  2001       Impact factor: 2.454

Review 2.  Muscle injuries and repair: current trends in research.

Authors:  Johnny Huard; Yong Li; Freddie H Fu
Journal:  J Bone Joint Surg Am       Date:  2002-05       Impact factor: 5.284

Review 3.  Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).

Authors:  David M Dohan Ehrenfest; Lars Rasmusson; Tomas Albrektsson
Journal:  Trends Biotechnol       Date:  2009-01-31       Impact factor: 19.536

4.  Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems.

Authors:  Tiffany N Castillo; Michael A Pouliot; Hyeon Joo Kim; Jason L Dragoo
Journal:  Am J Sports Med       Date:  2010-11-04       Impact factor: 6.202

Review 5.  Herbal medicines for osteoarthritis.

Authors: 
Journal:  Drug Ther Bull       Date:  2012-01

Review 6.  Platelet-rich plasma therapy: a systematic literature review and evidence for clinical use.

Authors:  Lauren H Redler; Scott A Thompson; Stephanie H Hsu; Christopher S Ahmad; William N Levine
Journal:  Phys Sportsmed       Date:  2011-02       Impact factor: 2.241

Review 7.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.

Authors:  Mohit Kapoor; Johanne Martel-Pelletier; Daniel Lajeunesse; Jean-Pierre Pelletier; Hassan Fahmi
Journal:  Nat Rev Rheumatol       Date:  2010-11-30       Impact factor: 20.543

Review 8.  Platelet-rich plasma for articular cartilage repair.

Authors:  Geoffrey D Abrams; Rachel M Frank; Lisa A Fortier; Brian J Cole
Journal:  Sports Med Arthrosc Rev       Date:  2013-12       Impact factor: 1.985

Review 9.  Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review.

Authors:  Y Zhu; M Yuan; H Y Meng; A Y Wang; Q Y Guo; Y Wang; J Peng
Journal:  Osteoarthritis Cartilage       Date:  2013-08-07       Impact factor: 6.576

10.  Fibroblastic response to treatment with different preparations rich in growth factors.

Authors:  E Anitua; M Sánchez; M M Zalduendo; M de la Fuente; R Prado; G Orive; I Andía
Journal:  Cell Prolif       Date:  2009-02-24       Impact factor: 6.831

View more
  3 in total

Review 1.  Ultrasound-guided procedures to treat sport-related muscle injuries.

Authors:  Davide Orlandi; Angelo Corazza; Alice Arcidiacono; Carmelo Messina; Giovanni Serafini; Luca M Sconfienza; Enzo Silvestri
Journal:  Br J Radiol       Date:  2015-11-12       Impact factor: 3.039

Review 2.  Growth factor delivery vehicles for tendon injuries: Mesenchymal stem cells and Platelet Rich Plasma.

Authors:  Alberto Guevara-Alvarez; Andreas Schmitt; Ryan P Russell; Andreas B Imhoff; Stefan Buchmann
Journal:  Muscles Ligaments Tendons J       Date:  2014-11-17

3.  Single Platelet-Rich Plasma Injection for Early Stage of Osteoarthritis of the Knee.

Authors:  Liborio Ingala Martini; Alessio Giai Via; Chiara Fossati; Filippo Randelli; Pietro Randelli; Davide Cucchi
Journal:  Joints       Date:  2017-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.